Archive
Gauteng Health pay chaos sparks doctor fury
Gauteng Health pay chaos leaves public doctors without expected overtime payments, revealing deep systemic issues in healthcare.
Read More
Pharmaceutical tariffs could hike drug costs by billions
Learn how pharmaceutical tariffs could raise U.S. drug costs by nearly $51 billion and impact American consumers.
Read More
Australia’s Crumbling Universal Healthcare: What’s Wrong?
Examine the realities of Australia’s crumbling universal healthcare system and how funding problems are affecting patients nationwide.
Read More
Antibiotic Resistance Claims Lives of Premature Babies
Antibiotic resistance claims lives in South African neonates, creating a critical public health crisis for vulnerable infants.
Read More
HIV deaths in SA may be four times higher than reported
The latest SAMRC study uncovers severe underreporting of HIV deaths in SA, revealing gaps that demand urgent public health attention.
Read More
PEPFAR Funding Cuts Threaten South Africa’s Health
Discover the alarming predictions concerning PEPFAR funding cuts: 65,000 additional AIDS deaths and 300,000 new infections by 2028.
Read More
NHI causes uncertainty for medical schemes
NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.
Read More
Adcock Ingram’s Urizone Wins Trademark Battle
Adcock Ingram’s Urizone receives legal protection as the court halts Cipla’s Furizome, citing trademark infringement.
Read More
Aspen Pharmacare Manufacturing Dispute Shrouded in Mystery
Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
Read More
NHI Advertising Campaign Proceeds Despite HIV Funding Shortfall
Health Minister Aaron Motsoaledi discusses the NHI advertising campaign designed to address misinformation and support health efforts.
Read More
Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
Read More
Clicks Interim Results Driven by Loyalty and Digital Sales
Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.
Read More